60

Nanjing Well Pharmaceutical Co LtdSHG 603351 Stock Report

Last reporting period 30 Sep, 2023

Updated 22 Oct, 2024

Last price

Market cap $B

0.393

Micro

Exchange

XSHG - Shanghai Stock Exchange

603351.SS Stock Analysis

60

Uncovered

Nanjing Well Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

33/100

Low score

Market cap $B

0.393

Dividend yield

1.39 %

Shares outstanding

130.67 B

Nanjing Well Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils. The company is headquartered in Nanjing, Jiangsu and currently employs 615 full-time employees. The company went IPO on 2019-01-30. Its main products include pharmaceutical auxiliary materials, synthetic lubricating base oil and pesticide additives. The firm distributes its products primarily in domestic market.

View Section: Eyestock Rating